Search results for "Highlights"
1-hour glucose value may predict mortality risk
A 1-hour glucose value above 155 mg/dL predicted mortality even when the 2-hour glucose value was below 140 mg/dL, according to the 33-year study.
https://diabetes.acponline.org/archives/2016/05/13/3.htm
13 May 2016
Switching to sulfonylureas from metformin monotherapy may increase risk of cardiovascular, hypoglycemic events
The results suggest that continuing metformin alone and accepting higher HbA1c targets may be preferable to switching to sulfonylureas when considering macrovascular outcomes and hypoglycemia, an accompanying editorial said.
https://diabetes.acponline.org/archives/2018/08/10/1.htm
10 Aug 2018
ADA's updated standards of diabetes care include recommendations for hypertension, screening high-risk youth
The American Diabetes Association (ADA)'s 2018 update also recommends that adults with type 2 diabetes and heart disease receive a medication proven to improve heart health, after lifestyle management and metformin.
https://diabetes.acponline.org/archives/2018/01/12/1.htm
12 Jan 2018
Metformin appears better than sulfonylureas as first-line therapy for patients with CKD
Metformin was associated with a lower risk of mortality than sulfonylureas both overall and in all categories of estimated glomerular filtration rate, the observational study found.
https://diabetes.acponline.org/archives/2017/12/08/1.htm
8 Dec 2017
Pioglitazone, but not rosiglitazone, associated with increased risk of bladder cancer
The results of this study pose the question of whether the increased likelihood of bladder cancer, which is rare, justifies withholding pioglitazone from adults with type 2 diabetes, according to an accompanying editorial.
https://diabetes.acponline.org/archives/2016/04/08/2.htm
8 Apr 2016
Pioglitazone use associated with reduced mortality risk, cohort analysis finds
The study did not find any consistent trend in mortality risk with increasing duration or dose, and the effect of pioglitazone on mortality was significantly modified by history of diabetes complications, chronic kidney disease, and macrovascular disease.
https://diabetes.acponline.org/archives/2018/02/09/1.htm
9 Feb 2018
Intensive therapy to lower HbA1c, BP, and cholesterol failed to reduce mortality
The trial included 2,542 patients ages 45 to 69 years who had type 2 diabetes with an HbA1c of 6.9% or higher and hypertension, dyslipidemia, or both, recruited at 81 sites in Japan.
https://diabetes.acponline.org/archives/2017/11/10/1.htm
10 Nov 2017
Incretin-based drugs not associated with greater heart failure hospitalization risk than other drug combos in retrospective study
Researchers compared patients taking dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues to those taking 2 or more oral antidiabetic drugs.
https://diabetes.acponline.org/archives/2016/04/08/3.htm
8 Apr 2016
VA's patient-centered model may not aid glycemic or lipid control
A retrospective cohort analysis assessed the impact of a change in primary care model on diabetes outcomes among patients receiving care at seven Midwestern Veterans Affairs facilities.
https://diabetes.acponline.org/archives/2018/04/13/1.htm
13 Apr 2018
Diabetes groups update standards for self-management
The 2017 revision from the American Diabetes Association and the American Association of Diabetes Educators offers recommendations on both diabetes self-management support and education.
https://diabetes.acponline.org/archives/2017/08/11/1.htm
11 Aug 2017